Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Elizabeth Orr

Washington, DC

Elizabeth Orr is managing editor of US regulatory and policy for Medtech Insight, which she joined in 2015 as a reporter focused on legal issues. She remains fascinated by the ever-changing master class on technology, government regulations, advances in health care and more that is covering the device industry. Elizabeth’s past employers include FDANews; DecisionHealth (formerly UCG); the Society of Interventional Radiology; and the Washington Examiner. A graduate of the College of Journalism at the University of Maryland College Park, she lives in Arlington, Va., with her husband and children.

Latest From Elizabeth Orr

CDC To Yank EUA On Original COVID-19 Test At Year’s End

The US body says it wants to encourage labs to use newer, faster alternatives that can also detect other pathogens.

Coronavirus COVID-19 Review Pathway

Recall Of Sleep, Ventilator Devices Lead To International Patient Suits For Philips

Patients in Canada and the US are suing Philips over issues related to the company’s recent recall of CPAPs, BiPAPs, and mechanical ventilators.

Regulation Respiratory

FDA Grants EUA For BD Blood Collection Tubes To Soften Shortage

Increased demand tied to COVID-19, plus supply chain difficulties, led to the blood collection device shortage, the US agency says.

Regulation FDA

Congressional Action Needed To Protect Device Supply Chain, FDA’s Woodcock Says

The US FDA needs enhanced authorities as well as increased funding to track and prevent device shortages, acting commissioner Janet Woodcock argues.

Policy FDA

‘Never Again’: Shuren Talks COVID-19 Lessons At FDA Small Business Event

Despite insisting that he would never want to relive the stressful days of 2020, US FDA device center chief Jeff Shuren said the pandemic nevertheless led to improvements in regulatory flexibility and communication with industry.

Policy FDA

Device Week, 16 July 2021 – An Inside Look At The EU’s Sweeping New Device Regs

In this week’s podcast, EU regulatory editor Amanda Maxwell walks us through the latest news and documents coming out of the European Union’s efforts to revamp its medical device and diagnostics rules and makes some predictions about what we can expect to see going forward.

Device Week Regulation
See All
UsernamePublicRestriction

Register